Literature DB >> 3653987

Production of a unique cytotoxin by Campylobacter jejuni.

R L Guerrant1, C A Wanke, R A Pennie, L J Barrett, A A Lima, A D O'Brien.   

Abstract

Campylobacter jejuni is an important diarrheal pathogen worldwide; the mechanisms by which it causes disease remain unclear. Because of its association with inflammatory diarrhea, we postulated that C. jejuni might produce a cytotoxin similar to that produced by Shigella sp., enterohemorrhagic Escherichia coli O157, or Clostridium difficile. Filtrates of 12 polymyxin-treated isolates of C. jejuni were placed on HeLa cells (sensitive to Shiga toxin cytotoxicity) and Chinese hamster ovary (CHO) cells. Of 12 isolates of C. jejuni tested, 5 killed 50% of the cells at greater than or equal to 1:4 dilutions of filtered suspensions of 10(9) bacteria per ml; killing was similar in HeLa and CHO cells (the CHO cells being insensitive to Shiga cytotoxin). One isolate produced a titer of 1:32 to 1:128. The relative potency in HeLa cells was comparable to that of E. coli strains that produce intermediate amounts of Shiga-like toxin. The other seven strains showed no cytotoxic effect, nor did the control diluents, polymyxin B, or supernatants of C. jejuni not treated with polymyxin B. Sonication also released active cytotoxin, but slightly less well than did polymyxin. The cytotoxic effect was dose dependent. Concentration of the C. jejuni in suspension by 10-fold before treatment with polymyxin B resulted in a 10-fold increase in the 50% cytotoxic dose. The cytotoxin effect was not neutralized by Shiga toxin immune serum against either Shiga-like toxin I or II or by anti-Clostridium difficile antiserum. The C jejuni cytotoxin was partially labile to trypsin (0.25%) and to heating to greater than or equal to 60 degrees C. Cytotoxicity was retained in Scientific Products dialysis tubing D1615-1 (Mr cutoff, 12,000 to 14,000). Some isolates of C. jejuni release a substance lethal to HeLa or CHO cells in vitro that is distinct from Shiga-like or Clostridium difficile toxin. This cytotoxin may contribute to the colonic mucosal invasive process that characterizes C. jejuni enteritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653987      PMCID: PMC260740          DOI: 10.1128/iai.55.10.2526-2530.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

Review 2.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

3.  Acute enteritis due to related vibrio: first positive stool cultures.

Authors:  P Dekeyser; M Gossuin-Detrain; J P Butzler; J Sternon
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

4.  Vibrio fetus infection in man. I. Ten new cases and some epidemiologic observations.

Authors:  V Bokkenheuser
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

Review 5.  Campylobacter enteritis.

Authors:  M J Blaser; L B Reller
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

6.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

7.  Detection of enteric campylobacteriosis in children.

Authors:  V D Bokkenheuser; N J Richardson; J H Bryner; D J Roux; A B Schutte; H J Koornhof; I Freiman; E Hartman
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

8.  Experimental Campylobacter diarrhea in chickens.

Authors:  G M Ruiz-Palacios; E Escamilla; N Torres
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

9.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

10.  Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections.

Authors:  R L Guerrant; R G Lahita; W C Winn; R B Roberts
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

View more
  20 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

3.  Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene.

Authors:  C L Pickett; E C Pesci; D L Cottle; G Russell; A N Erdem; H Zeytin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni.

Authors:  S Mahajan; F G Rodgers
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

6.  Possible pathogenic mechanisms of Campylobacter pylori.

Authors:  D Fumarola; G Miragliotta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

7.  Campylobacter jejuni and Campylobacter coli in children from communities in Northeastern Brazil: molecular detection and relation to nutritional status.

Authors:  Josiane da Silva Quetz; Ila Fernanda Nunes Lima; Alexandre Havt; Eunice Bobo de Carvalho; Noélia Leal Lima; Alberto Melo Soares; Rosa Maria Salani Mota; Richard Littleton Guerrant; Aldo Angelo Moreira Lima
Journal:  Diagn Microbiol Infect Dis       Date:  2010-07       Impact factor: 2.803

8.  Quantitative analysis and partial characterization of cytotoxin production by Salmonella strains.

Authors:  S Ashkenazi; T G Cleary; B E Murray; A Wanger; L K Pickering
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Incidence of toxigenic Campylobacter strains in South Africa.

Authors:  H E Bok; A S Greeff; H H Crewe-Brown
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

10.  Iron acquisition and hemolysin production by Campylobacter jejuni.

Authors:  C L Pickett; T Auffenberg; E C Pesci; V L Sheen; S S Jusuf
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.